DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ensituximab
Ensituximab
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
Tanibirumab (CUI C3490677) Add to Cart
(12) United States Patent (10) Patent No.: US 9,161,992 B2 Jefferies Et Al
2017 Immuno-Oncology Medicines in Development
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
The Two Tontti Tudiul Lui Hi Ha Unit
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
Orphan Drug Designation List
(INN) for Biological and Biotechnological Substances
Ep 3321281 A1
INN Working Document 05.179 Update 2011
Stembook 2018.Pdf
INN Working Document 05.179 Update December 2010
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
2018 Medicines in Development for Cancer
(INN) for Biological and Biotechnological Substances
International Nonproprietary Names for Pharmaceutical Substances (INN)
N° 18380 A61k 31/5377 (2018.01) A61p 35/02 (2018.01)
Top View
Novel Agents in Early Phase Clinical Studies on Refractory Pancreatic Cancer Highlights from the “2012 ASCO Gastrointestinal Cancers Symposium”
Methods and Compositions for Prediction of Therapeutic Efficacy of Cancer Treatments and Cancer Prognosis Upon Antibody Treatment
( 12 ) United States Patent
2020 Medicines in Development ꟷ Cancer
Biotechnology Presented by America’S Biopharmaceutical Research Companies
Supplementary Tables and Figures Section 1. Distribution of CDR-H3
Oncology Drugs in the Pipeline
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Personalized Healthcare in Oncology: Past, Present and Future
Oncology Drugs in the Pipeline
Cancer Immunotherapy Beyond Immune Checkpoint Inhibitors Julian A
QSAR Model Development for Early Stage Screening of Monoclonal Antibody Therapeutics to Facilitate Rapid Developability
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Cancer PRESENTEDBYAMERICA ’ SBIOPHARMACEUTICALRESEARCHCOMPANIES Nearly 900 Medicines and Vaccines in Testing Offer Hope in the Fight Against Cancer
WO 2013/119960 A2 15 August 2013 (15.08.2013) P O P C T
(INN) for Biological and Biotechnological Substances
Novel Immunotherapeutic Approach in Gastric Cancer
Ep 3088005 A1
CAPTURE Study 2089
Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
(12) Patent Application Publication (10) Pub. No.: US 2015/0374790 A1 Liu Et Al